BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30252748)

  • 21. Medical treatment of rosacea with emphasis on topical therapies.
    Del Rosso JQ
    Expert Opin Pharmacother; 2004 Jan; 5(1):5-13. PubMed ID: 14680431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Randomized-Controlled Trial of Oral Low-Dose Isotretinoin for Difficult-To-Treat Papulopustular Rosacea.
    Sbidian E; Vicaut É; Chidiack H; Anselin E; Cribier B; Dréno B; Chosidow O
    J Invest Dermatol; 2016 Jun; 136(6):1124-1129. PubMed ID: 26854486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significant and Sustained Response with Short Cycle of Low-Dose Isotretinoin in Morbihan Disease.
    Gil F; Aranha J; Andrade I
    Skinmed; 2022; 20(2):157-158. PubMed ID: 35532775
    [No Abstract]   [Full Text] [Related]  

  • 24. A Tailored Approach to the Treatment of a Patient with a Severe Dynamic Manifestation of Rosacea: A Case Report.
    Schaller M; Gonser L
    Drugs R D; 2016 Sep; 16(3):279-283. PubMed ID: 27623792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and histological features and treatment outcomes of patients with Morbihan disease: a systematic review.
    Mayur O; Martinez R; McNichol MC; McGee JS
    Arch Dermatol Res; 2023 Oct; 315(8):2427-2429. PubMed ID: 37062777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morbihan Syndrome, a UK Case Series.
    Yvon C; Mudhar HS; Fayers T; Siah WF; Malhotra R; Currie Z; Tan J; Rajak S
    Ophthalmic Plast Reconstr Surg; 2020; 36(5):438-443. PubMed ID: 31990896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morbihan disease.
    Hu SW; Robinson M; Meehan SA; Cohen DE
    Dermatol Online J; 2012 Dec; 18(12):27. PubMed ID: 23286817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morbihan disease treated with Tripterygium wilfordii successfully.
    Yu X; Qu T; Jin H; Fang K
    J Dermatol; 2018 May; 45(5):e122-e123. PubMed ID: 29165836
    [No Abstract]   [Full Text] [Related]  

  • 29. Topical metronidazole. A review of its use in rosacea.
    McClellan KJ; Noble S
    Am J Clin Dermatol; 2000; 1(3):191-9. PubMed ID: 11702300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of rosacea.
    Parodi A; Drago F; Paolino S; Cozzani E; Gallo R
    Ann Dermatol Venereol; 2011 Nov; 138 Suppl 3():S211-4. PubMed ID: 22183101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.
    Dahl MV; Jarratt M; Kaplan D; Tuley MR; Baker MD
    J Am Acad Dermatol; 2001 Nov; 45(5):723-30. PubMed ID: 11606923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study.
    Koçak M; Yağli S; Vahapoğlu G; Ekşioğlu M
    Dermatology; 2002; 205(3):265-70. PubMed ID: 12399675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial.
    Koca R; Altinyazar HC; Ankarali H; Muhtar S; Tekin NS; Cinar S
    Clin Exp Dermatol; 2010 Apr; 35(3):251-6. PubMed ID: 19594764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing obstetric outcomes of rosacea fulminans in pregnancy: report of three cases with review of pathogenesis and management.
    Jarrett R; Gonsalves R; Anstey AV
    Clin Exp Dermatol; 2010 Dec; 35(8):888-91. PubMed ID: 20456381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Canadian Clinical Practice Guidelines for Rosacea.
    Asai Y; Tan J; Baibergenova A; Barankin B; Cochrane CL; Humphrey S; Lynde CW; Marcoux D; Poulin Y; Rivers JK; Sapijaszko M; Sibbald RG; Toole J; Ulmer M; Zip C
    J Cutan Med Surg; 2016 Sep; 20(5):432-45. PubMed ID: 27207355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adapalene vs. metronidazole gel for the treatment of rosacea.
    Altinyazar HC; Koca R; Tekin NS; Eştürk E
    Int J Dermatol; 2005 Mar; 44(3):252-5. PubMed ID: 15807740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updates on the pathophysiology and management of acne rosacea.
    Elsaie ML; Choudhary S
    Postgrad Med; 2009 Sep; 121(5):178-86. PubMed ID: 19820288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A status report on the medical management of rosacea: focus on topical therapies.
    Del Rosso JQ
    Cutis; 2002 Nov; 70(5):271-5. PubMed ID: 12469780
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea.
    Ertl GA; Levine N; Kligman AM
    Arch Dermatol; 1994 Mar; 130(3):319-24. PubMed ID: 8129410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eruption in a patient with Crohn disease.
    Gavrilova M; Alonso V; Martin-Gorgojo A; Rubio M; Ramon D; Monteagudo C; Jorda-Cuevas E
    JAMA Dermatol; 2013 Jan; 149(1):97-102. PubMed ID: 23324767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.